News Releases

June 2018

June 15, 2018 6/15/2018 Takeda Further Expands Help At Hand Patient Assistance Program in U.S.

June 3, 2018 6/3/2018 Takeda Highlights Favorable Safety Profile of Entyvio® (vedolizumab) Through Comparative Real-World Data Versus TNFα-Antagonist Therapy in Ulcerative Colitis and Crohn’s Disease

May 2018

May 24, 2018 5/24/2018 Takeda Supports Illinois Bicentennial Stem Fusion Program

May 5, 2018 5/5/2018 Takeda Activities at American Psychiatric Association (APA) Annual Meeting Innovation Zone Highlight Advancements in Mental Health

May 2, 2018 5/2/2018 TRINTELLIX® (vortioxetine) Prescribing Information Now Includes New Data Showing Improvement in Processing Speed, an Important Aspect of Cognitive Function in Acute Major Depressive Disorder (MDD)

March 2018

March 12, 2018 3/12/2018 Takeda Announces Results from Uloric® (febuxostat) Cardiovascular Outcomes Trial

February 2018

February 6, 2018 2/6/2018 Takeda Announces Publication of Study Utilizing State-of-the-Art Modeling to Better Understand Optimal Treatment Positioning for Patients with Ulcerative Colitis

January 2018

January 23, 2018 1/23/2018 Takeda Utilizes Social Media Analysis and Survey in a Study to Better Understand Patient Preferences When Seeking Treatment for Inflammatory Bowel Disease